Mihovil Spoljaric

Mihovil Spoljaric has worked in the finance and accounting industry since 2010. Mihovil began their career as a Finance & Controlling Trainee at EconGas GmbH in 2010, before joining Elanco as a Junior Financial Analyst & Compliance Support in 2011. During their time at Elanco, they were promoted to Financial Analyst & Compliance Reviewer and then Senior Financial Analyst & Compliance Reviewer. In 2015, Mihovil joined Nabriva Therapeutics plc as a Senior Financial Analyst and was subsequently promoted to Assistant Director, Financial Reporting and Controlling and Managing Director, Nabriva Therapeutics GmbH. Most recently, they were appointed as VP, Corporate Controller at F2G in 2022.

Mihovil Spoljaric completed a Bachelor of Science in Business Administration and Management from WU (Vienna University of Economics and Business) between 2006 and 2011.